Log in

Relevant bibliographies by topics / Demyelinating diseases/Multiple sclerosis / Books

To see the other types of publications on this topic, follow the link: Demyelinating diseases/Multiple sclerosis.

Books on the topic 'Demyelinating diseases/Multiple sclerosis'

Author: Grafiati

Published: 4 June 2021

Last updated: 15 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Demyelinating diseases/Multiple sclerosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Rodriguez, Moses, ed. Advances in multiple Sclerosis and Experimental Demyelinating Diseases. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-73677-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Satellite Symposium on Myelination and Demyelination: Implications for Multiple Sclerosis (1987 Vancouver, B.C.). Myelination and demyelination: Implications for multiple sclerosis. New York: Plenum Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Demyelinating disorders of the central nervous system in childhood. Cambridge: Cambridge University Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rosner, Louis J. Multiple sclerosis. New York: Prentice Hall Press, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Multiple sclerosis. London: Routledge, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gold, Susan Dudley. Multiple sclerosis. Parsippany, N.J: Crestwood House, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Multiple sclerosis. Parsippany, N.J: Crestwood House, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Understanding multiple sclerosis. Jackson: University Press of Mississippi, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Rudick, Richard A., and Jeffrey A. Cohen. Multiple sclerosis therapeutics. 4th ed. Cambridge: Cambridge University Press, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Multiple sclerosis therapeutics. 4th ed. Cambridge: Cambridge University Press, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Women living with multiple sclerosis. Alameda, CA: Hunter House Publishers, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Saunders, Carol. What nurses know-- multiple sclerosis. New York: Demos Health, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Saunders, Carol. What nurses know-- multiple sclerosis. New York: Demos Health, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Miller, Aaron E. Multiple sclerosis in clinical practice. London: Martin Dunitz, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

D, Lublin Fred, and Coyle Patricia K, eds. Multiple sclerosis in clinical practice. London: Martin Dunitz, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Samkoff, Lawrence M., and Andrew D. Goodman. Multiple sclerosis and CNS inflammatory disorders. Chichester, West Sussex, UK: John Wiley & Sons Inc., 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

The clinical neuropsychiatry of multiple sclerosis. Cambridge, U.K: Cambridge University Press, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Nichols, Judith Lynn. Living beyond multiple sclerosis: A women's guide. Alameda, CA: Hunter House, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Gingold, Jeffrey N. Facing the cognitive challenges of multiple sclerosis. New York, N.Y: Demos Health, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Gingold, Jeffrey N. Facing the cognitive challenges of multiple sclerosis. New York, NY: Demos Medical Pub., 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Holland, Nancy J. Multiple sclerosis: A guide for the newly diagnosed. 2nd ed. New York: Demos Vermande, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Holland, Nancy J. Multiple sclerosis: A guide for the newly diagnosed. New York: Demos Vermande, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Holland, Nancy J. Multiple sclerosis: A self-care guide to wellness. 2nd ed. New York: Demos, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Murray, T. J. Multiple sclerosis: A guide for the newly diagnosed. 4th ed. New York, NY: Demos Health, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Kennedy, Patricia. The can do multiple sclerosis guide to lifestyle empowerment. New York, NY: Demos Medical Pub., 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Richer, Catherine Balsdon. Occupational therapy practice guidelines for adults with neurodegenerative diseases: Multiple sclerosis, transverse myelitis, and amyotrophic lateral sclerosis. Bethesda, Md: American Occupational Therapy Association, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Apel, Melanie Ann. Let's talk about living with a parent with multiple sclerosis. New York: Powerkids Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Mackie, Carole. Me and my shadow: Learning to live with multiple sclerosis. London: Aurum, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Going the distance: Living a full life with multiple sclerosis and other debilitating diseases. New York: Dutton, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

service), ScienceDirect (Online, ed. Neuroinflammation. Amsterdam: North Holland, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Coyle, Patricia K. Living with progressive mulitple sclerosis: Overcoming the challenges. 2nd ed. New York, NY: Demos Medical Pub., 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Shelley, Ross, ed. Multiple sclerosis: New hope and practical advice for people with MS and their families. New York: Simon & Schuster, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Rosner, Louis J. Multiple sclerosis: New hope and practical advice for people with MS and their families. New York: Fireside Book, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

1936-, Bennett Hal Zina, ed. You are not your illness: Seven principles for meeting the challenge. New York: Simon & Schuster, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Fife, Bruce. Stop Alzheimer's now!: How to prevent and reverse dementia, Parkinson's, ALS, multiple sclerosis, and other neurodegenerative disorders. Colorado Springs, CO: Piccadilly Books, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

S, Freedman Mark, ed. Multiple sclerosis and demyelinating diseases. Philadelphia: Lippincott Williams & Wilkins, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Multiple Sclerosis and Demyelinating Diseases (Advances in Neurology). Lippincott Williams & Wilkins, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Compston, Alastair. Multiple sclerosis and other demyelinating diseases. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569381.003.0871.

Full text

Abstract:

The oligodendrocyte–myelin unit subserves saltatory conduction of the nerve impulse in the healthy central nervous system. At one time, many disease processes were thought exclusively to target the structure and function of myelin. Therefore, they were designated ‘demyelinating diseases’. But recent analyses, based mainly on pathological and imaging studies, (re)emphasize that axons are also directly involved in these disorders during both the acute and chronic phases. Another ambiguity is the extent to which these are inflammatory conditions. Here, distinctions should be made between inflammation, as a generic process, and autoimmunity in which rather a specific set of aetiological and mechanistic conditions pertain. And there are differences between disorders that are driven primarily by immune processes and those in which inflammation occurs in response to pre-existing tissue damage.With these provisos, the pathological processes of demyelination and associated axonal dysfunction often account for episodic neurological symptoms and signs referable to white matter tracts of the brain, optic nerves, or spinal cord when these occur in young people. This is the clinical context in which the possibility of ‘demyelinating disease’ is usually considered by physicians and, increasingly, the informed patient. Neurologists will, with appropriate cautions, also be prepared to diagnose demyelinating disease in older patients presenting with progressive symptoms implicating these same pathways even when there is no suggestive past history. Both in its typical and atypical forms multiple sclerosis remains by far the commonest demyelinating disease. But acute disseminated encephalomyelitis, the leucodystrophies, and central pontine myelinolysis also need to be considered in particular circumstances; and multiple sclerosis itself has a differential diagnosis in which the relapsing-remitting course is mimicked by conditions not associated with direct injury to the axon–glial unit. Since our understanding of the cause, pathogenesis and features of demyelinating disease remains incomplete, classification combines aspects of the aetiology, clinical features, pathology, and laboratory components. Whether the designation ‘multiple sclerosis’ encapsulates one or more conditions is now much debated. We anticipate that a major part of future studies in demyelinating disease will be further to resolve this question of disease heterogeneity leading to a new taxonomy based on mechanisms rather than clinical empiricism. But, for now, the variable ages of onset, unpredictable clinical course, protean clinical manifestations, and non-specific laboratory investigations continue to make demyelinating disease one of the more challenging diagnostic areas in clinical neurology.

APA, Harvard, Vancouver, ISO, and other styles

39

Kaplan, Tamara, and Tracey Milligan. Demyelinating Diseases 1: Multiple Sclerosis (DRAFT). Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190650261.003.0013.

Full text

Abstract:

The video in this chapter explores demyelinating diseases, and focuses on multiple sclerosis (MS). It discusses the causes of MS, its etiology, symptoms (optic neuritis, sensory changes, weakness, spasticity, and bowel and bladder dysfunction), and subtypes (relapsing remitting (RRMS), secondary progressive (SPMS), and primary progressive (PPMS)).

APA, Harvard, Vancouver, ISO, and other styles

40

J, Vinken P., and Koetsier Johan C, eds. Demyelinating diseases. Amsterdam: Elsevier Science Publishers, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Moses, Rodriguez, ed. Advances in multiple sclerosis and experimental demyelinating diseases. Berlin: Springer, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Brochet, Bruno. Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Rodriguez, Moses. Advances in Multiple Sclerosis and Experimental Demyelinating Diseases. Springer, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Misulis, Karl E., and E. Lee Murray. Demyelinating Diseases. Edited by Karl E. Misulis and E. Lee Murray. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190259419.003.0022.

Full text

Abstract:

The hospital neurologist is often consulted to coordinate the evaluation and management of a host of known or suspected demyelinating diseases. Among the most common are multiple sclerosis, acute disseminated encephalomyelitis, optic neuritis, and transverse myelitis.

APA, Harvard, Vancouver, ISO, and other styles

45

Index of RCRA Regulatory Interpretations. Elsevier Science Ltd, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Bhargava, Pavan, and Peter A. Calabresi. Multiple Sclerosis. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0087.

Full text

Abstract:

Multiple sclerosis is a chronic demyelinating neurological disorder of the brain and spinal cord, with both inflammatory and degenerative components. Current treatment strategies utilize immunomodulatory and immunosuppressive agents to reduce the inflammatory disease activity and retard accumulation of disability. Future challenges for treatment include identifying agents that will promote remyelination and axonal protection to help impact progressive forms of multiple sclerosis. This chapter discusses currently available disease modifying therapies, agents currently in phase 2/3 trials, and future directions in the treatment of multiple sclerosis.

APA, Harvard, Vancouver, ISO, and other styles

47

Keegan, B. Mark. Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases: Case-Based Learning. Cambridge University Press, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Tillema, Jan-Mendelt, J. Graves, L. A. Benson, G. S. Aaen, A. Belman, J. Parrish, B. Weinstock-Guttman, L. Krupp, T. Chitnis, and E. Wauban. Pediatric Multiple Sclerosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.003.0022.

Full text

Abstract:

Increased interest in pediatric-onset multiple sclerosis (MS) has contributed to improved knowledge of the presentation and evolution of central nervous system demyelinating diseases in childhood. This chapter reviews the unique features and challenges related to pediatric MS. The close proximity of pediatric MS to the biological onset of the disease provides a unique window into disease pathogenesis at stages of life when innate and adaptive immune pathways are still maturing. It is expected that the interplay between genetics, epigenetics, environmental exposures, and the maturing central nervous system in children with MS will provide important insights into the earliest phases of the disease. This chapter reviews the unique features that distinguish pediatric patients with MS from their adult counterparts. Specific emphasis is placed on the work-up and management of these patients in the context of current knowledge.

APA, Harvard, Vancouver, ISO, and other styles

49

Guo, Yong, and Claudia F. Lucchinetti. Taking a Microscopic Look at Multiple Sclerosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.003.0005.

Full text

Abstract:

The pathology of multiple sclerosis is complex, extends beyond the white matter plaque, and is influenced by stage of demyelinating activity, clinical course, disease duration, and treatment. Technological advances in immunology, molecular biology, and “omic” biology have provided novel insights into the mechanisms for development of white matter plaques, axonal damage, cortical demyelination, and disease progression. Detailed, systematic, and statistically rigorous pathological studies on clinically well-characterized MS cohorts have helped define the heterogeneous pathological substrates of MS and unravel the complex molecular pathogenic mechanisms, with the ultimate goal of identifying targets for therapeutic interventions. It is increasingly clear that the use of human tissues is imperative to improve current diagnostic, prognostic, and therapeutic modalities. Preclinical animal models have been invaluable for discovery of key immune processes, basic disease mechanisms, and candidate immune targeting strategies, but the conclusions have yet be reconciled with the essential features of the human disease.

APA, Harvard, Vancouver, ISO, and other styles

50

Kim, Seung U. Myelination and Demyelination: Implications for Multiple Sclerosis. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!